| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $477.2M | +3.0% |
| Cost of Revenue | $149.4M | +15.4% |
| Gross Profit | $327.8M | -1.8% |
| R&D Expense | $93.9M | -20.8% |
| SG&A Expense | $151.9M | +8.1% |
| Operating Income | -$5.44B | -193.8% |
| Pre-tax Income | -$5.53B | -185.7% |
| Income Tax | -$1.68B | -118.6% |
| Net Income | -$3.85B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.30B | +5937.9% |
| Accounts Receivable | $205.7M | +13.5% |
| Current Assets | $2.56B | +916.2% |
| Total Assets | $61.64B | +138.5% |
| Current Liabilities | $456.5M | +28.5% |
| Long-term Debt | $8.19B | +13.9% |
| Total Liabilities | $10.60B | +39.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.2M | -26.8% |
| Capital Expenditures | $8.2M | +175.8% |
| Investing Cash Flow | -$22.51B | -1.9% |
| Financing Cash Flow | $24.84B | +12.2% |
| Free Cash Flow | -$75.5M | -34.7% |
| -229.8% |
| EPS (Basic) | -$15.23 | -151.3% |
| EPS (Diluted) | -$15.23 | -151.3% |
| Stockholders' Equity |
| $44.12B |
| +142.0% |